Synaptic degeneration in Alzheimer disease
Alzheimer disease (AD) is characterized by progressive cognitive decline in older
individuals accompanied by the presence of two pathological protein aggregates—amyloid …
individuals accompanied by the presence of two pathological protein aggregates—amyloid …
Beyond erectile dysfunction: cGMP-specific phosphodiesterase 5 inhibitors for other clinical disorders
Cyclic guanosine monophosphate (cGMP), an important intracellular second messenger,
mediates cellular functional responses in all vital organs. Phosphodiesterase 5 (PDE5) is …
mediates cellular functional responses in all vital organs. Phosphodiesterase 5 (PDE5) is …
Nitric oxide/cGMP/CREB pathway and amyloid-beta crosstalk: from physiology to Alzheimer's disease
MR Tropea, W Gulisano, V Vacanti, O Arancio… - Free Radical Biology …, 2022 - Elsevier
The nitric oxide (NO)/cGMP pathway has been extensively studied for its pivotal role in
synaptic plasticity and memory processes, resulting in an increase of cAMP response …
synaptic plasticity and memory processes, resulting in an increase of cAMP response …
Tau toxicity in neurodegeneration
SY Liang, ZT Wang, L Tan, JT Yu - Molecular Neurobiology, 2022 - Springer
Tau is a microtubule-associated protein widely distributed in the central nervous system
(CNS). The main function of tau is to promote the assembly of microtubules and stabilize …
(CNS). The main function of tau is to promote the assembly of microtubules and stabilize …
Development of novel phosphodiesterase 5 inhibitors for the therapy of Alzheimer's disease
Nitric oxide (NO) is a gaseous molecule that plays a multifactorial role in several cellular
processes. In the central nervous system, the NO dual nature in neuroprotection and …
processes. In the central nervous system, the NO dual nature in neuroprotection and …
CREB: a multifaceted target for Alzheimer's disease
Alzheimer's disease (AD) is a persistent neuropathological stipulation manifested in the form
of neuronal/synapse demise, the formation of senile plaques, hyperphosphorylated tau …
of neuronal/synapse demise, the formation of senile plaques, hyperphosphorylated tau …
Neuroprotective Effect of NO-Delivery Dinitrosyl Iron Complexes (DNICs) on Amyloid Pathology in the Alzheimer's Disease Cell Model
WH Chuang, YT Chou, YH Chen, TH Kuo… - ACS Chemical …, 2023 - ACS Publications
Alzheimer's disease (AD) is a neurodegenerative disorder characterized by cognitive
impairment, memory loss, and behavioral deficits. β-amyloid1–42 (Aβ1–42) aggregation is a …
impairment, memory loss, and behavioral deficits. β-amyloid1–42 (Aβ1–42) aggregation is a …
Therapeutic potential of phosphodiesterase inhibitors against neurodegeneration: The perspective of the medicinal chemist
Increasing human life expectancy prompts the development of novel remedies for cognitive
decline: 44 million people worldwide are affected by dementia, and this number is predicted …
decline: 44 million people worldwide are affected by dementia, and this number is predicted …
Synaptic mitochondria: an early target of amyloid-β and tau in Alzheimer's disease
AK Torres, C Jara, HS Park-Kang… - Journal of …, 2021 - content.iospress.com
Alzheimer's disease (AD) is characterized by cognitive impairment and the presence of
neurofibrillary tangles and senile plaques in the brain. Neurofibrillary tangles are composed …
neurofibrillary tangles and senile plaques in the brain. Neurofibrillary tangles are composed …
Differential microRNA expression analyses across two brain regions in Alzheimer's disease
V Dobricic, M Schilling, J Schulz, LS Zhu… - Translational …, 2022 - nature.com
Dysregulation of microRNAs (miRNAs) is involved in the pathogenesis of
neurodegenerative diseases, including Alzheimer's disease (AD). Hitherto, sample sizes …
neurodegenerative diseases, including Alzheimer's disease (AD). Hitherto, sample sizes …